Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 2;8(6):e2517291.
doi: 10.1001/jamanetworkopen.2025.17291.

Intraosseous vs Intravenous Access for Epinephrine in Pediatric Out-of-Hospital Cardiac Arrest

Affiliations

Intraosseous vs Intravenous Access for Epinephrine in Pediatric Out-of-Hospital Cardiac Arrest

Masashi Okubo et al. JAMA Netw Open. .

Abstract

Importance: While epinephrine is commonly administered in children with out-of-hospital cardiac arrest (OHCA) via an intraosseous (IO) or intravenous (IV) route, the optimal route of epinephrine delivery is unclear.

Objective: To evaluate the association between the route of epinephrine administration (IO or IV) and patient outcomes after pediatric OHCA.

Design, setting, and participants: Retrospective cohort study of pediatric patients (aged <18 years) with nontraumatic OHCA treated by emergency medical services who received prehospital epinephrine either via an IO or IV route. Patients were included in the Resuscitation Outcomes Consortium Epidemiologic Registry, a prospective OHCA registry at 10 sites in the US and Canada from April 2011 to June 2015. Data analysis was performed from May 2024 to April 2025.

Exposure: Epinephrine administration route: IO or IV route.

Main outcomes and measures: The primary outcome was survival to hospital discharge. The secondary outcome was return of spontaneous circulation (ROSC) before hospital arrival. Propensity scores were calculated and inverse probability of treatment weighting (IPTW) was performed with stabilized weights to control imbalances in measured patient demographics, cardiac arrest characteristics, and bystander and prehospital interventions.

Results: Of 739 eligible patients (median [IQR] age, 1 [0-11] years), 449 (60.8%) were male. Epinephrine was administered via an IO route for 535 (72.4%) and via an IV route for 204 (27.6%) patients. In the IPTW pseudopopulation (740 weighted cases), there was no significant difference in survival to hospital discharge (IO epinephrine: 28 of 528 patients [5.3%] vs IV epinephrine: 12 of 212 patients [5.7%]; risk ratio [RR], 0.92; 95% CI, 0.41-2.07) or prehospital ROSC (IO epinephrine: 76 of 528 patients [14.4%] vs IV epinephrine: 46 of 212 patients [21.7%]; RR, 0.66; 95% CI, 0.42-1.03) between the IO and IV epinephrine groups.

Conclusions and relevance: In this retrospective cohort study of pediatric patients with OHCA in the US and Canada, the route of epinephrine administration was not associated with survival to hospital discharge or prehospital ROSC. This may support the practice of administering epinephrine via IO or IV route.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Owusu-Ansah reported being a consultant for Prodigy EMS outside the submitted work. Dr Ramgopal reported receiving grants from the Gerber Foundation, the Pediatric Pandemic Network, and the National Heart, Lung and Blood Institute outside the submitted work. Dr Callaway reported receiving grants from the National Institutes of Health (NIH), the American Heart Association, and the Society for Academic Emergency Medicine during the conduct of the study. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Patient Flow
EMS indicates emergency medical services; IO, intraosseous; IV, intravenous; OHCA, out-of-hospital cardiac arrest; ROSC, return of spontaneous circulation.
Figure 2.
Figure 2.. Cumulative Proportion of Patients Without Return of Spontaneous Circulation (ROSC) Over Time From Epinephrine Administration and Advanced Life Clinician Arrival in the Weighted Population, Stratified by the Route of Epinephrine Administration
A, Log-rank P = .29. The hazard ratio for the IO group was 0.71 (95% CI, 0.43-1.20). B, Log-rank P = .41. The hazard ratio for the IO group was 0.77 (95% CI, 0.47-1.28). IO indicates intraosseous; IV, intravenous.

Similar articles

References

    1. Okubo M, Chan HK, Callaway CW, Mann NC, Wang HE. Characteristics of paediatric out-of-hospital cardiac arrest in the United States. Resuscitation. 2020;153:227-233. doi: 10.1016/j.resuscitation.2020.04.023 - DOI - PubMed
    1. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation. 2022;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052 - DOI - PubMed
    1. Amoako J, Komukai S, Izawa J, Callaway CW, Okubo M. Evaluation of use of epinephrine and time to first dose and outcomes in pediatric patients with out-of-hospital cardiac arrest. JAMA Netw Open. 2023;6(3):e235187. doi: 10.1001/jamanetworkopen.2023.5187 - DOI - PMC - PubMed
    1. Fink EL, Prince DK, Kaltman JR, et al. ; Resuscitation Outcomes Consortium . Unchanged pediatric out-of-hospital cardiac arrest incidence and survival rates with regional variation in North America. Resuscitation. 2016;107:121-128. doi: 10.1016/j.resuscitation.2016.07.244 - DOI - PMC - PubMed
    1. Topjian AA, Raymond TT, Atkins D, et al. ; Pediatric Basic and Advanced Life Support Collaborators . Part 4: pediatric basic and advanced life support: 2020 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2020;142(16_suppl_2)(suppl 2):S469-S523. doi: 10.1161/CIR.0000000000000901 - DOI - PubMed